Advanced Search
ZHOU Xingqin, ZHAO Hongyu, SONG Yao, CHEN Wenjuan, SHEN Chaoyan, JI Bin. Therapeutic Effect of Elemene Combined with Chemoradiotherapy and Its Influence on Immune Function in Nasopharyngeal Carcinoma Patients[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1118-1122. DOI: 10.3971/j.issn.1000-8578.2019.19.0669
Citation: ZHOU Xingqin, ZHAO Hongyu, SONG Yao, CHEN Wenjuan, SHEN Chaoyan, JI Bin. Therapeutic Effect of Elemene Combined with Chemoradiotherapy and Its Influence on Immune Function in Nasopharyngeal Carcinoma Patients[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1118-1122. DOI: 10.3971/j.issn.1000-8578.2019.19.0669

Therapeutic Effect of Elemene Combined with Chemoradiotherapy and Its Influence on Immune Function in Nasopharyngeal Carcinoma Patients

More Information
  • Corresponding author:

    JI Bin, E-mail:jbrobert@163.com

  • Received Date: May 20, 2019
  • Revised Date: October 10, 2019
  • Available Online: January 12, 2024
  • Objective 

    To observe the therapeutic effect of elemene emulsion injection combined with chemoradiotherapy and its effect on immune function in nasopharyngeal carcinoma (NPC) patients.

    Methods 

    Random number method was used to divide the patients into control group (IMRT+fluorouracil+cisplatin) and observation group (IMRT+fluorouracil+cisplatin+elemene injection 500 mg/d). We evaluated the short-term efficacy, the changes of T lymphocyte subsets in peripheral blood and adverse reactions.

    Results 

    All patients successfully completed the treatment. There was statistically significant difference between control group and observation group in the total effective rate (71.74% vs. 82.61%, P < 0.05), CD8+ level in peripheral blood lymphocyte subsets (31.35±2.39 vs. 34.37±1.97, P < 0.05), the ratio of CD4+/CD8+ (1.37±0.03 vs. 0.98±0.18, P < 0.05), and the quality of life (57.2±7.4 vs. 60.3±5.3, P < 0.05). Compared with control group, the observation group had lower hematological toxicity and grade Ⅲ-Ⅳ skin reactions, and the incidence of grade Ⅲ-Ⅳ gastrointestinal reactions (nausea, vomiting) was significantly lower (P < 0.05).

    Conclusion 

    Elemene combined with chemoradiotherapy could improve the quality of life of nasopharyngeal carcinoma patients, reduce the incidence of adverse reactions and obtain a better prognosis.

  • [1]
    Mott FE, Ferrarotto R, Nguyen T, et al. Nasopharyngeal carcinoma outcome with induction chemotherapy followed by concurrent chemoradiotherapy[J]. Oral Oncol, 2018, 81: 75-80. doi: 10.1016/j.oraloncology.2018.04.020
    [2]
    Wang M, Xu Y, Chen X, et al. Prognostic significance of residual or recurrent lymph nodes in the neck for patients with nasopharyngeal carcinoma after radiotherapy[J]. J Cancer Res Ther, 2016, 12(2): 909-914. doi: 10.4103/0973-1482.168969
    [3]
    Jiang X, Hidru TH, Zhang Z, et al. Evidence of elemene injection combined radiotherapy in lung cancer treatment among patients with brain metastases: A systematic review and meta-analysis[J]. Medicine(Baltimore), 2017, 96(21): e6963. http://cn.bing.com/academic/profile?id=f2f36fabea943d4e004f1b48ed997416&encoded=0&v=paper_preview&mkt=zh-cn
    [4]
    Li LJ, Zhong LF, Jiang LP, et al. β-Elemene Radiosensitizes Lung Cancer A549 Cells by Enhancing DNA Damage and Inhibiting DNA Repair[J]. Phytother Res, 2011, 25(7): 1095-1097. doi: 10.1002/ptr.3367
    [5]
    Yao YQ, Ding X, Jia YC, et al. Anti-tumor effect of β-elemene in glioblastoma cells depends on p38 MAPK activation[J]. Cancer Lett, 2008, 264(1): 127-134. doi: 10.1016-j.canlet.2008.01.049/
    [6]
    Liu JS, He SC, Zhang ZL, et al. Anticancer effects of β-elemene in gastric cancer cells and its potential underlying proteins: A proteomic study[J]. Oncol Rep, 2014, 32(6): 2635-2647. doi: 10.3892/or.2014.3490
    [7]
    王跃建.鼻咽癌诊断和治疗[M].北京:人民卫生出版社, 2013, 288-307.

    Wang YJ. Diagnosis and treatment of nasopharyngeal carcinoma[M]. Beijing: People's Health Publishing House, 2013, 288-307.
    [8]
    中国鼻咽癌临床分期工作委员会. 2010鼻咽癌调强放疗靶区及剂量设计指引专家共识[J].中华放射肿瘤学杂志, 2011, 20(4): 267-269. doi: 10.3760/cma.j.issn.1004-4221.2011.04.001

    Working committee for the clinical stage nasopharyngealcarcinoma (NPC) in China. 2010 expert consensus of nasopharyngeal carcinoma IMRT target and dosage design[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi, 2011, 20(4): 267-269. doi: 10.3760/cma.j.issn.1004-4221.2011.04.001
    [9]
    Tang LQ, Chen DP, Guo L, et al. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage Ⅱ-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial[J]. Lancet Oncol, 2018, 19(4): 461-473. doi: 10.1016/S1470-2045(18)30104-9
    [10]
    Shimada M, Itamochi H, Kigawa J. Nedaplatin: a cisplatin derivative in cancer chemotherapy[J]. Cancer Manag Res, 2013, 5: 67-76. http://d.old.wanfangdata.com.cn/Periodical/zl201106011
    [11]
    Chen L, Liu LZ, Chen M, et al. Prognostic value of subclass-sification using MRI in the T4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment[J]. Int J Radiat Oncol Biol Phys, 2012, 84(1): 196-202. doi: 10.1016/j.ijrobp.2011.11.021
    [12]
    Petersson F. Nasopharyngeal carcinoma: a review[J]. Semin Diagn Pathol, 2015, 32(1): 54-73. doi: 10.1053/j.semdp.2015.02.021
    [13]
    谭明, 廖天志, 向东华.调强适形放疗对鼻咽癌患者治疗效果及免疫功能的影响[J].癌症进展, 2019, 17(3): 308-310. http://d.old.wanfangdata.com.cn/Periodical/azjz201903015

    Tan M, Liao TZ, Xiang DH. The clinical efficacy of IMRT and the influence on immune function of patients with nasopharyngeal carcinoma[J]. Ai Zheng Jin Zhan, 2019, 17(3): 308-310. http://d.old.wanfangdata.com.cn/Periodical/azjz201903015
    [14]
    杨娜, 郭启帅, 汪春雨, 等.基于Meta分析同步放化疗比单纯放疗治疗晚期鼻咽癌更有效[J].基因组学与应用生物学, 2018, 37(1): 164-169. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jyzxyyyswx201801025

    Yang N, Guo QS, Wang CY, et al. The Concurrent Chemoradiation is More Effective than Radiation Alone in the Treatment of Advanced Nasopharyngeal Carcinoma Based on Meta-analysis[J]. Ji Yin Zu Xue Yu Ying Yong Sheng Wu Xue, 2018, 37(1): 164-169. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jyzxyyyswx201801025
    [15]
    Chen W, Lu Y, Wu J, et al. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis[J]. Cancer Chemother Pharmacol, 2011, 67(4): 799-808. doi: 10.1007/s00280-010-1378-x
    [16]
    Wu J, Tang Q, Yang L, et al. Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells[J]. Sci Rep, 2017, 7(1): 509. doi: 10.1038/s41598-017-00626-6
    [17]
    Liu J. Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis[J]. Front Med, 2011, 5(1): 101-105. doi: 10.1007/s11684-011-0111-4
    [18]
    周云, 万丹影, 钱晓倩, 等.榄香烯注射液联合吉非替尼改善表皮生长因子受体突变非小细胞肺癌晚期患者免疫功能及生活质量的效果[J].中国临床保健杂志, 2017, 20(5): 502-505. doi: 10.3969/J.issn.1672-6790.2017.05.006

    Zhou Y, Wan DY, Qian XQ, et al. Effect of elemene injection combined with gefitinib on immune function and life quality of advanced elder lung cancer patients with EGFR mutant[J]. Zhongguo Lin Chuang Bao Jian Za Zhi, 2017, 20(5): 502-505. doi: 10.3969/J.issn.1672-6790.2017.05.006
    [19]
    雷俊华, 刘韵, 曾江正, 等.榄香烯注射液联合化疗对晚期非小细胞肺癌患者免疫功能及疗效的影响[J].临床肿瘤学杂志, 2018, 23(2): 160-163. doi: 10.3969/j.issn.1009-0460.2018.02.013

    Lei JH, Liu Y, Zeng JZ, et al. Influence of Elemene Injection plus chemotherapy on the immune function and curative effect in patients with advanced non-small cell lung cancer[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2018, 23(2): 160-163. doi: 10.3969/j.issn.1009-0460.2018.02.013
  • Related Articles

    [1]LIU Jianbo, LI Baiyu, KE Shanbao, ZHANG Wei. Cordycepin Attenuates Immune Function Injury in A Rat Model of Lung Cancer After Radiotherapy by Inhibiting JAK2/STAT3 Pathway[J]. Cancer Research on Prevention and Treatment, 2021, 48(11): 994-998. DOI: 10.3971/j.issn.1000-8578.2021.21.0094
    [2]WEI Xueling, LAN Mei, PENG Xinhao, ZHANG Hanyi, LONG En, LIU Hui, LANG Jinyi. Correlation Between Immune Function Status and EBV DNA in Patients with Nasopharyngeal Carcinoma and Their Influence on Prognosis[J]. Cancer Research on Prevention and Treatment, 2021, 48(6): 600-606. DOI: 10.3971/j.issn.1000-8578.2021.20.1402
    [3]GUI Chao, DENG Wankai, LIU Xiguo. Expression and Biological Functions of Sestrin2 in Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2019, 46(5): 421-425. DOI: 10.3971/j.issn.1000-8578.2019.18.1469
    [4]CHEN Jinghua, TAN Wenyong, XU Ruilian, XIA Junxian, ZHU Meiqin. Clinical Efficacy of Gemcitabine plus S-1 on Refractory Nasopharyngeal Carcinoma Patients and Their Influence on Immune Function[J]. Cancer Research on Prevention and Treatment, 2018, 45(12): 1014-1019. DOI: 10.3971/j.issn.1000-8578.2018.18.0443
    [5]YANG Xinrui, WANG Gang, JI Libin, WANG Haiyan. Effects of Arenaria Kansuensis Aqueous Extract on Immune Function of H22 Tumorbearing Mice[J]. Cancer Research on Prevention and Treatment, 2015, 42(07): 662-665. DOI: 10.3971/j.issn.1000-8578.2015.07.005
    [6]YA Han-qing, WANG Wei-xing, HUANG Shun-rong, XU Sheng. Effects of Total Parenteral Nutrition Supplemented with Glutamine and Arginine on Postoperative Immune Function in Patients with Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2007, 34(12): 965-967. DOI: 10.3971/j.issn.1000-8578.50
    [7]CHEN Yan, WANG Xi-cai, WU Zhi-ping, JIN Cong-guo, GU Yu-lan, CHEN Xiao-qun. Epstein-Barr Virus Infection and Its Correlation to Changes of Cell Immunity in Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2005, 32(10): 608-609. DOI: 10.3971/j.issn.1000-8578.654
    [8]Zhang jiluan, . The level of red cell immune function and serm saliva acid in the patients with malignant tumor[J]. Cancer Research on Prevention and Treatment, 1998, 25(5): 353-354.
    [9]Huang Guo, . Effect of low ionizing radiation on tumor metastasis and immune function of mice[J]. Cancer Research on Prevention and Treatment, 1996, 23(3): 160-163.
    [10]Zhang HElong, . The erythrocyte immune function of lung cancer patients and the relationship with C_3, CIC,T lymphocyte subsets[J]. Cancer Research on Prevention and Treatment, 1995, 22(3): 133-134.

Catalog

    Article views (1739) PDF downloads (287) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return